Literature DB >> 2114219

Switch circular DNA formed in cytokine-treated mouse splenocytes: evidence for intramolecular DNA deletion in immunoglobulin class switching.

M Matsuoka1, K Yoshida, T Maeda, S Usuda, H Sakano.   

Abstract

We have characterized circular DNA in mouse splenocytes treated with the mitogen lipopolysaccharide (LPS) and various cytokines, including transforming growth factor beta (TGF-beta) and interleukin 4 (IL-4). Using probes of immunoglobulin heavy chain constant genes (CH), excision products of class switch recombination were identified. The majority of the clones contained the 3' portion of the switch mu (S mu) region and the 5' portion of other switch regions. Some clones contained 3'-S gamma sequences instead of 3'-S mu. This indicates that isotype switching may occur not only from C mu, but also from one of the C gamma genes to other CH genes further down-stream. In the presence of LPS, the cytokine TGF-beta enhanced the detection of 5'-S alpha-positive clones, while the lymphokine IL-4 enhanced 5'-S gamma 1 positives. The data support the notion that TGF-beta and IL-4 can direct isotype-specific class switching.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114219     DOI: 10.1016/0092-8674(90)90247-c

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  61 in total

Review 1.  In vivo and in vitro studies of immunoglobulin gene somatic hypermutation.

Authors:  J E Sale; M Bemark; G T Williams; C J Jolly; M R Ehrenstein; C Rada; C Milstein; M S Neuberger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  Variable deletion and duplication at recombination junction ends: implication for staggered double-strand cleavage in class-switch recombination.

Authors:  X Chen; K Kinoshita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Two new isotype-specific switching activities detected for Ig class switching.

Authors:  Limei Ma; Henry H Wortis; Amy L Kenter
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

4.  A proposed mechanism for promoter-associated DNA rearrangement events at a variant surface glycoprotein gene expression site.

Authors:  K M Gottesdiener; L Goriparthi; J P Masucci; L H Van der Ploeg
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

5.  Transcriptional regulatory elements stimulate recombination in extrachromosomal substrates carrying immunoglobulin switch-region sequences.

Authors:  H Leung; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  B-cell proliferation initiated by Ia cross-linking and sustained by interleukins leads to class switching but not somatic mutation in vitro.

Authors:  L J Wysocki; G Creadon; K R Lehmann; J C Cambier
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

7.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

8.  A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs.

Authors:  K Kinoshita; M Harigai; S Fagarasan; M Muramatsu; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  A DNA break- and phosphorylation-dependent positive feedback loop promotes immunoglobulin class-switch recombination.

Authors:  Kayleigh Herrick-Reynolds; Bharat Vaidyanathan; Joseph N Pucella; Bao Q Vuong; Anna J Ucher; Nina M Donghia; Xiwen Gu; Laura Nicolas; Urszula Nowak; Numa Rahman; Matthew P Strout; Kevin D Mills; Janet Stavnezer; Jayanta Chaudhuri
Journal:  Nat Immunol       Date:  2013-10-06       Impact factor: 25.606

10.  Rad51 expression and localization in B cells carrying out class switch recombination.

Authors:  M J Li; M C Peakman; E I Golub; G Reddy; D C Ward; C M Radding; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.